558 related articles for article (PubMed ID: 24217719)
1. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome.
Thomsen M; Nordestgaard BG
JAMA Intern Med; 2014 Jan; 174(1):15-22. PubMed ID: 24217719
[TBL] [Abstract][Full Text] [Related]
2. Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort.
Cao X; Zhou J; Yuan H; Wu L; Chen Z
BMC Nephrol; 2015 Jun; 16():85. PubMed ID: 26084279
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and lifestyle predictors of ischemic heart disease and all-cause mortality among normal weight, overweight, and obese men: a 16-year follow-up in the Copenhagen Male Study.
Suadicani P; Hein HO; von Eyben FE; Gyntelberg F
Metab Syndr Relat Disord; 2009 Apr; 7(2):97-104. PubMed ID: 19032035
[TBL] [Abstract][Full Text] [Related]
4. Prepregnancy obesity and associations with stroke and myocardial infarction in women in the years after childbirth: a nationwide cohort study.
Schmiegelow MD; Andersson C; Køber L; Andersen SS; Olesen JB; Jensen TB; Azimi A; Nielsen MB; Gislason G; Torp-Pedersen C
Circulation; 2014 Jan; 129(3):330-7. PubMed ID: 24146252
[TBL] [Abstract][Full Text] [Related]
5. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.
Arnlöv J; Ingelsson E; Sundström J; Lind L
Circulation; 2010 Jan; 121(2):230-6. PubMed ID: 20038741
[TBL] [Abstract][Full Text] [Related]
6. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
Nordestgaard BG; Benn M; Schnohr P; Tybjaerg-Hansen A
JAMA; 2007 Jul; 298(3):299-308. PubMed ID: 17635890
[TBL] [Abstract][Full Text] [Related]
7. Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trøndelag Health Study), Norway.
Mørkedal B; Vatten LJ; Romundstad PR; Laugsand LE; Janszky I
J Am Coll Cardiol; 2014 Mar; 63(11):1071-8. PubMed ID: 24345592
[TBL] [Abstract][Full Text] [Related]
8. Should central obesity be an optional or essential component of the metabolic syndrome? Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study.
Lee J; Ma S; Heng D; Tan CE; Chew SK; Hughes K; Tai ES
Diabetes Care; 2007 Feb; 30(2):343-7. PubMed ID: 17259505
[TBL] [Abstract][Full Text] [Related]
9. Metabolically Healthy Obesity and Ischemic Heart Disease: A 10-Year Follow-Up of the Inter99 Study.
Hansen L; Netterstrøm MK; Johansen NB; Rønn PF; Vistisen D; Husemoen LLN; Jørgensen ME; Rod NH; Færch K
J Clin Endocrinol Metab; 2017 Jun; 102(6):1934-1942. PubMed ID: 28323999
[TBL] [Abstract][Full Text] [Related]
10. Predictors of weight change in overweight patients with myocardial infarction.
Fadl YY; Krumholz HM; Kosiborod M; Masoudi FA; Peterson PN; Reid KJ; Weintraub WS; Buchanan DM; Spertus JA
Am Heart J; 2007 Oct; 154(4):711-7. PubMed ID: 17892997
[TBL] [Abstract][Full Text] [Related]
11. Body composition and body fat distribution in relation to later risk of acute myocardial infarction: a Danish follow-up study.
Stegger JG; Schmidt EB; Obel T; Berentzen TL; Tjønneland A; Sørensen TI; Overvad K
Int J Obes (Lond); 2011 Nov; 35(11):1433-41. PubMed ID: 21285940
[TBL] [Abstract][Full Text] [Related]
12. Visible age-related signs and risk of ischemic heart disease in the general population: a prospective cohort study.
Christoffersen M; Frikke-Schmidt R; Schnohr P; Jensen GB; Nordestgaard BG; Tybjærg-Hansen A
Circulation; 2014 Mar; 129(9):990-8. PubMed ID: 24334176
[TBL] [Abstract][Full Text] [Related]
13. Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease.
Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
J Clin Endocrinol Metab; 2008 Oct; 93(10):3769-76. PubMed ID: 18682504
[TBL] [Abstract][Full Text] [Related]
14. Body mass index and adverse events in patients with incident atrial fibrillation.
Overvad TF; Rasmussen LH; Skjøth F; Overvad K; Lip GY; Larsen TB
Am J Med; 2013 Jul; 126(7):640.e9-17. PubMed ID: 23601271
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
Wittrup HH; Andersen RV; Tybjaerg-Hansen A; Jensen GB; Nordestgaard BG
J Clin Endocrinol Metab; 2006 Apr; 91(4):1438-45. PubMed ID: 16418216
[TBL] [Abstract][Full Text] [Related]
16. Association between the metabolically healthy obese phenotype and the risk of myocardial infarction: results from the Kailuan study.
Xu Y; Li H; Wang A; Su Z; Yang G; Luo Y; Tao L; Chen S; Wu S; Wang Y; Guo X
Eur J Endocrinol; 2018 Dec; 179(6):343-352. PubMed ID: 30400019
[TBL] [Abstract][Full Text] [Related]
17. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
[TBL] [Abstract][Full Text] [Related]
18. Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes.
Eisenstein EL; McGuire DK; Bhapkar MV; Kristinsson A; Hochman JS; Kong DF; Califf RM; Van de Werf F; Yancy WS; Newby LK
Am J Med; 2005 Sep; 118(9):981-90. PubMed ID: 16164884
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome in non-obese Taiwanese: new definition of metabolically obese, normal-weight individual.
Tsai CH
Chin Med J (Engl); 2009 Nov; 122(21):2534-9. PubMed ID: 19951566
[TBL] [Abstract][Full Text] [Related]
20. Central obesity: predictive value of skinfold measurements for subsequent ischaemic heart disease at 14 years follow-up in the Caerphilly Study.
Yarnell JW; Patterson CC; Thomas HF; Sweetnam PM
Int J Obes Relat Metab Disord; 2001 Oct; 25(10):1546-9. PubMed ID: 11673779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
